Does TRT-induced erythrocytosis actually increase venous thromboembolism risk in clinical practice?
PARTIALLY ADDRESSED
Despite FDA warnings and a 315% increased erythrocytosis risk with TRT, the association between elevated hematocrit and actual VTE events remains inconclusive. This uncertainty hampers evidence-based risk-benefit decisions for millions of aging men considering TRT.
Gap type: open_question
Source paper: Erythrocytosis and Polycythemia Secondary to Testosterone Replacement Therapy in the Aging Male. (2015, Sexual medicine reviews, PMID:27784544)
Priority: 0.89Domain: endocrinologyHypotheses: 0
📊 Landscape Analysis
Landscape Summary:
Does TRT-induced erythrocytosis actually increase venous thromboembolism risk in clinical practice? is a 0.89 priority gap in endocrinology.
It has 0 linked hypotheses with average composite score 0.000.
Status: partially_addressed.
Key Unanswered Questions
What is the optimal TREM2 modulation strategy across disease stages?
How does DAM activation state affect therapeutic outcomes?
What biomarkers predict response to TREM2-targeted interventions?
Key Researchers
Colonna, Sevlever, et al. (TREM2 biology)
Clinical Trials
Does TRT-induced erythrocytosis actually increase venous thromboembolism risk in clinical practice? — INVOKE-2 (completed)
📈 Living Dashboards
0
Hypotheses
0.000
Top Score
0.000
Avg Score
0
Debates
0.00
Avg Quality
60%
Resolution
0
Mechanistic Families
Gap Resolution Progress60%
Hypothesis Score Distribution
🏆 Competing Hypotheses (Ranked by Score)
No hypotheses linked to this gap yet.
🌊 Knowledge Graph Connections
No knowledge graph edges recorded
🕑 Activity Feed
✏update on knowledge_gapby max_gmail2026-04-28T00:44
✏update on knowledge_gapby None2026-04-25T22:15
✏update on knowledge_gapby None2026-04-13T21:49
✏update on knowledge_gapby None2026-04-13T21:49
💬 Discussion
No discussions yet. Be the first to comment.
📋 Investigation Sub-Tasks
Create sub-tasks to investigate specific aspects of this gap:
Find more evidence for top-scoring hypotheses
Run multi-agent debate on unresolved sub-questions